Search Browse Earnings

CorMedix Inc.

Nasdaq:CRMD

Pharmaceutical Preparations·PARSIPPANY, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CorMedix Inc. — SlamSEC

Revenue

$43.5M

-0.0% YoY

FY 2025

Adj. EBITDA

-$22.2M

-51.1% margin

FY 2025

Net Income

-$17.9M

-41.2% margin

FY 2025

EPS (Diluted)

-$0.30

FY 2025

Stock Price

$6.46

+2.6%

2026-03-06

52W Range

$5.60 – $17.43

P/E Ratio

-21.5x

Market Cap

$510.7M

Cash

$40.7M

FY 2025

Total Debt

—

Net Cash

$40.7M

FY 2025

Enterprise Value

$470.0M

Debt / EBITDA

1.8x

FY 2025

EV / EBITDA

-21.2x

Employees

—

CEO

Todisco Joseph

CFO

Blum Susan